The ins and outs of IL-7R-mediated signaling in leukemia
João Barata
Instituto Medicina Molecular [Lisboa, Portugal]
21/03/2019 to 01/01/0001
Time: 12:30:00
Salón de Actos del Centro de Investigación del Cáncer
Interleukin 7 (IL-7) and its receptor (IL-7R, a heterodimer of IL-7Rα and γc) are essential for normal lymphoid development. In their absence, severe combined immunodeficiency occurs. By contrast, excessive IL-7/IL-7R-mediated signaling can drive lymphoid leukemia development, disease acceleration and resistance to chemotherapy. Combining different in vitro and in vivo models we have been trying to understand how IL-7R-mediated signaling works in leukemic cells (as opposed to norm